Pharmacist Collaboration in the Care of Patients with Diabetes within the Primary Care Clinic Setting

Overview

Información sobre este estudio

The primary aim of this study is to compare the outcome measures of adult ECH type 2 diabetes patients who were referred to onsite pharmacist services for management of their diabetes to similar patients who were not referred for pharmacy service management of their diabetes. A secondary aim of the study is to assess the Kasson providers’ satisfaction level and estimated pharmacy service referral frequency to their patients. A tertiary aim of the study is to compare the hospitalization rates of type 2 diabetes rates who were referred to onsite pharmacist services for management of their diabetes to similar patients who were not referred for pharmacy service management of their diabetes.

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

  • Research authorized
  • Adult patients (ages 18 and over)
  • Patients empanelled to the Mayo ECH practices in Rochester and Kasson, Minnesota
  • Patients with a diagnosis of Type 2 Diabetes Mellitus and an A1c reading greater than 8% recorded from April 1, 2012-June 30, 2016.

Exclusion Criteria:

  • Pregnancy (within the study time period April 2012 through September 2016)
  • Baseline A1c
  • Referral to Endocrinology in month prior to pharmacist referral

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus

Rochester, Minn.

Investigador principal de Mayo Clinic

Amanda Davis, Pharm.D., R.Ph.

Cerrado para la inscripción

More information

Publicaciones

Publications are currently not available
.
CLS-20304706

Mayo Clinic Footer